What’s Next: Life Sciences at a Crossroads

In this rapidly evolving market, biotech and life sciences leaders are under growing pressure to make complex decisions during times of uncertainty.

Tune in for What’s Next: Life Sciences at a Crossroads, our webinar series that brings together legal advisors, industry voices, and capital market leaders to explore timely challenges. Designed to be short, sharp, and strategic, each session will equip you with actionable takeaways — from financing and corporate governance to IP strategy, cross-border risk, and regulatory developments.

Upcoming Webinar

The Rules of Innovation: How IP, Law, and Regulation Shape the MedTech Market | May 13 (2:00 PM ET)

Most MedTech companies treat regulation and IP as overhead. The most resilient ones are built differently. Join Goodwin and QMB for a direct conversation with practitioners on how legal strategy, regulatory governance, and IP management work together to create durable competitive advantage and leave with a framework for turning compliance into a structural asset.

Speakers:

• Julie Tibbets, Partner, Goodwin
• Marty Gomez, Partner, Goodwin
• Steven Tjoe, Partner, Goodwin
• Michel Moravia, Chairman, QMB

REGISTER